RZH
Relyea Zuckerberg Hanson’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.65M | Buy |
15,340
+417
| +3% | +$44.8K | 0.19% | 75 |
|
2025
Q1 | $1.51M | Buy |
14,923
+73
| +0.5% | +$7.36K | 0.2% | 73 |
|
2024
Q4 | $1.33M | Sell |
14,850
-563
| -4% | -$50.3K | 0.18% | 81 |
|
2024
Q3 | $1.29M | Buy |
15,413
+146
| +1% | +$12.2K | 0.2% | 72 |
|
2024
Q2 | $1.18M | Buy |
15,267
+268
| +2% | +$20.6K | 0.2% | 73 |
|
2024
Q1 | $1.03M | Buy |
14,999
+229
| +2% | +$15.7K | 0.18% | 74 |
|
2023
Q4 | $854K | Sell |
14,770
-464
| -3% | -$26.8K | 0.17% | 81 |
|
2023
Q3 | $804K | Buy |
15,234
+46
| +0.3% | +$2.43K | 0.18% | 77 |
|
2023
Q2 | $822K | Sell |
15,188
-118
| -0.8% | -$6.38K | 0.18% | 78 |
|
2023
Q1 | $766K | Buy |
15,306
+223
| +1% | +$11.2K | 0.19% | 76 |
|
2022
Q4 | $698K | Buy |
15,083
+199
| +1% | +$9.21K | 0.2% | 71 |
|
2022
Q3 | $576K | Sell |
14,884
-392
| -3% | -$15.2K | 0.21% | 72 |
|
2022
Q2 | $569K | Sell |
15,276
-218
| -1% | -$8.12K | 0.21% | 73 |
|
2022
Q1 | $688K | Buy |
15,494
+195
| +1% | +$8.66K | 0.23% | 68 |
|
2021
Q4 | $657K | Sell |
15,299
-5,899
| -28% | -$253K | 0.24% | 74 |
|
2021
Q3 | $920K | Sell |
21,198
-783
| -4% | -$34K | 0.36% | 48 |
|
2021
Q2 | $940K | Buy |
21,981
+189
| +0.9% | +$8.08K | 0.39% | 42 |
|
2021
Q1 | $924K | Sell |
21,792
-2,058
| -9% | -$87.3K | 0.41% | 40 |
|
2020
Q4 | $857K | Hold |
23,850
| – | – | 0.46% | 40 |
|
2020
Q3 | $930K | Hold |
23,850
| – | – | 0.6% | 32 |
|
2020
Q2 | $837K | Hold |
23,850
| – | – | 0.67% | 33 |
|
2020
Q1 | $778K | Hold |
23,850
| – | – | 0.85% | 31 |
|
2019
Q4 | $1.08M | Buy |
+23,850
| New | +$1.08M | 1.03% | 25 |
|